Tags Archives: CytoSorb

Perfusfind S.L.

Abstract Venlafaxine is a serotonin and noradrenalin reuptake inhibitor prescribed as an antidepressant. Overdose clinically manifests with neurological, cardiovascular and gastrointestinal abnormalities based on, amongst others, serotonin syndrome and can..

Perfusfind S.L.

This case reports on a 43-year-old pregnant woman, who was hospitalized for an anticipated complicated delivery. [pdf-embedder url="https://perfusfind.com/wp-content/uploads/2021/05/CoW_19_2021_E_web_compressed.pdf"]

Perfusfind S.L.

This case reports on a 34-year-old male patient with a history of heavy alcohol intake (1 bottle of wine per day for the past 15 years) but no other comorbidities,..

Perfusfind S.L.

ISICEM Symposium 2023      

Perfusfind S.L.

This case reports on a 56-year-old female patient who was admitted to hospital by ambulance with fever (up to 42°C) that had been persisting for 4 days, lower abdominal pain..

Perfusfind S.L.

This case reports on a 60-year-old male patient who presented to hospital for elective aortocoronary bypass surgery. [pdf-embedder url="https://perfusfind.com/wp-content/uploads/2023/03/CoM_02_2023_E_web_compressed.pdf"]  

Perfusfind S.L.

Abstract PRINCETON, N.J., March 07, 2023 (GLOBE NEWSWIRE) --  (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood purification, announces that..

Perfusfind S.L.

Removal of antithrombotics in Cardiac Surgery – Update of current knowledge Dr. Efthymios Deliargyris, Princeton/USA  

Perfusfind S.L.

Abstract Background ECMO support is associated with the development of a systemic hyper-inflammatory response, which may become quite significant and extreme in some cases. We hypothesize that Cytosorb or Jafron..

Perfusfind S.L.

This case reports on a 20-year-old patient with no relevant medical history, who was admitted to the emergency room with severe polytrauma after hitting a stationary car whilst on his..

Perfusfind S.L.

This case reports on an a 14-year-boy (43 kg) without any respiratory symptoms, who was admitted to a regional hospital with a fever of one day associated with vomiting and..

Perfusfind S.L.

This case reports on an 18-year-old male without relevant medical history, who presented at the emergency room of a peripheral primary care hospital with nausea and headaches. [pdf-embedder url="https://perfusfind.com/wp-content/uploads/2022/12/CoW_42_2022_E_web_compressed.pdf"]

Perfusfind S.L.

This case reports on an a 67-year-old woman with CHILD-C liver cirrhosis, who was admitted to the tertiary intensive care unit (ICU) after intoxication with bromazepam. [pdf-embedder url="https://perfusfind.com/wp-content/uploads/2022/12/CoW_41_2022_E_web_compressed.pdf"]  

Perfusfind S.L.

This case reports on a 68-year-old male with known arterial hypertension, who presented at the hospital by ambulance following severe deterioration of his general condition including fever up to 39°C,..

Perfusfind S.L.

This case reports on a 37-year-old male patient who was referred from a peripheral hospital with the diagnosis of Dengue fever and multiple organ failure. [pdf-embedder url="https://perfusfind.com/wp-content/uploads/2022/11/CoW_39_2022_E_web_compressed.pdf"]  

Perfusfind S.L.

This case reports on an 81-year-old man who presented to the hospital with methicillin-sensitive Staphylococcus aureus prosthetic aortic valve endocarditis and hemodynamic instability requiring an urgent operation (EuroSCORE II 31.05%)..

Perfusfind S.L.

This case reports on a 55-year-old man with hepatocellular carcinoma in the context of a hepatitis C virus (HCV)-infection since the year 2000, who was hospitalized and scheduled for an..

Perfusfind S.L.

Abstract What is known and objective Emergent cardiac surgery in patients under anticoagulant therapy is still a major point of concern. Recently approved reversal agents are often not available or..

Perfusfind S.L.

This report describes the case of a 73-year-old male patient (known pre-existing conditions: bilateral peripheral vascular disease grade 2b, hypercholesterolemia with long-term simvastatin medication) who was admitted to the Emergency..

Perfusfind S.L.

Abstract PRINCETON, N.J., Nov. 2, 2022 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: ), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using its CytoSorb® blood purification technology,..

Perfusfind S.L.

This case reports on a 12-year-old male patient (weight 55 kg) without relevant medical history, who was admitted to the hospital with a three days history of fever associated with..

Perfusfind S.L.

Hemoadsorption in infective endocarditis and antithrombotic removal in the cardiosurgical setting: an update Prof. Dr. med. Daniel Wendt Update of the current literature Patient selection Cost effectiveness Outlook    ..

Perfusfind S.L.

This case reports on an a 74-year-old male patient who was admitted to Artemed Klinikum Munich South, for urgent coronary artery bypass grafting (CABG) for severe three-vessel disease (occluded right..

Perfusfind S.L.

This report describes the case of a 68-year-old patient (known medical history: untreated chronic obstructive pulmonary disease (COPD), ectopic atrial tachycardia, liver cirrhosis CHILD stage B, no contact with physicians..

Perfusfind S.L.

Abstract Acute respiratory distress syndrome (ARDS) is associated with high morbidity and mortality. Adjunct hemoadsorption is increasingly utilized to target underlying hyperinflammation derived from ARDS. This article aims to review..

Perfusfind S.L.

Recording CytoSorbents Lunch Symposium at the EACTS 2022 Lunch Symposium at the EACTS 2022 October 7th 2022 Hemoadsorption with CytoSorb in high-risk cardiac surgery indications – new data 00:00 -..

Perfusfind S.L.

Abstract Background: Patients on direct oral anticoagulants are at high risk of perioperative bleeding complicaapitions. We analyzed the results of intraoperative hemoadsorption (HA) in patients undergoing cardiac surgery who were..

Perfusfind S.L.

Abstract Introduction: Immunomodulatory therapies have shown beneficial effects in patients with severe COVID-19. Patients with hypercytokinemia might benefit from the removal of inflammatory mediators via hemadsorption. Methods: Single-center prospective randomized trial at..

Perfusfind S.L.

This case reports on a 20-day old newborn (weight 3.1 kg, body surface area 0.20 m2), who was diagnosed with an extreme tetralogy of Fallot presenting in a severe cyanotic..

Perfusfind S.L.

Abstract Extracorporeal hemoadsorption with the CytoSorb adsorber is increasingly being used during the past years. The use in combination with extracorporeal membrane oxygenation (ECMO) is feasible, but frequency of its use and..